Department of Radiology

Publications

2018

Takahashi H, Watanabe Y, Tanaka H, Mihara M, Mochizuki H, Takahashi K, et al. Comprehensive MRI quantification of the substantia nigra pars compacta in Parkinson's disease. Eur J Radiol. 2018;109:48-56.

Fox JJ, Gavane SC, Blanc-Autran E, Nehmeh S, Gönen M, Beattie B, et al. Positron Emission Tomography/Computed Tomography-Based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-Resistant Prostate Cancer. JAMA Oncol. 2018;4(2):217-224.

Zhang J, Cho J, Zhou D, Nguyen TD, Spincemaille P, Gupta A, et al. Quantitative susceptibility mapping-based cerebral metabolic rate of oxygen mapping with minimum local variance. Magn Reson Med. 2018;79(1):172-179.

Ippoliti M, Adams LC, Winfried B, Hamm B, Spincemaille P, Wang Y, et al. Quantitative susceptibility mapping across two clinical field strengths: Contrast-to-noise ratio enhancement at 1.5T. J Magn Reson Imaging. 2018;48(5):1410-1420.

Kim Y, Zhang Z, Shim J-, Lee TS, Tung C-. A cell surface clicked navigation system to direct specific bone targeting. Bioorg Med Chem. 2018;26(3):758-764.

Aaron RK, Racine JR, Voisinet A, Evangelista P, Dyke JP. Subchondral bone circulation in osteoarthritis of the human knee. Osteoarthritis Cartilage. 2018;26(7):940-944.

Wang X, Yang B, Adams MP, Gao X, Karakatsanis NA, Tang J. Improved myocardial perfusion PET imaging with MRI assisted reconstruction incorporating multi-resolution joint entropy. Phys Med Biol. 2018;63(17):175017.

Mosconi L, Rahman A, Diaz I, Wu X, Scheyer O, Hristov HW, et al. Increased Alzheimer's risk during the menopause transition: A 3-year longitudinal brain imaging study. PLoS One. 2018;13(12):e0207885.

Kelly J, Amor-Coarasa A, Ponnala S, Nikolopoulou A, Williams C, Schlyer D, et al. Trifunctional PSMA-targeting constructs for prostate cancer with unprecedented localization to LNCaP tumors. Eur J Nucl Med Mol Imaging. 2018;45(11):1841-1851.

Fortea J, Carmona-Iragui M, Benejam B, Fernández S, Videla L, Barroeta I, et al. Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study. Lancet Neurol. 2018;17(10):860-869.